In fact, recently, it has been shown that the serum containing DPPIV activity in patients with stable COPD (722–1,037 ng/ml) is significantly lower than healthy people (1,080–1,620 ng/ml) (Holst and Deacon, 2005). Here, DPP4 is linked to chronic obstructive pulmonary disease.